Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone
- PMID: 11086885
- DOI: 10.1248/cpb.48.1606
Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone
Abstract
Seven metabolites were isolated after anaerobic incubation of secoisolariciresinol diglucoside (1) with a human fecal suspension. They were identified as (-)-secoisolariciresinol (2), 3-demethyl-(-)-secoisolariciresinol (3), 2-(3-hydroxybenzyl)-3-(4-hydroxy-3-methoxybenzyl)butane-1,4-diol (4), didemethylsecoisolariciresinol (5), 2(3-hydroxybenzyl)-3-(3,4-dihydroxybenzyl)butane-1,4-diol (6), enterodiol (7) and enterolactone (8). Furthermore, two bacterial strains, Peptostreptococcus sp. SDG-1 and Eubacterium sp. SDG-2, responsible for the transformation of 1 to a mammalian lignan 7, were isolated from a human fecal suspension. The former transformed 2 to 3 and 5, as well as 4 to 6, and the latter transformed 5 to 6 and 7.
Similar articles
-
Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside.FEMS Microbiol Ecol. 2006 Mar;55(3):471-8. doi: 10.1111/j.1574-6941.2005.00057.x. FEMS Microbiol Ecol. 2006. PMID: 16466386
-
Biotransformation of pinoresinol diglucoside to mammalian lignans by human intestinal microflora, and isolation of Enterococcus faecalis strain PDG-1 responsible for the transformation of (+)-pinoresinol to (+)-lariciresinol.Chem Pharm Bull (Tokyo). 2003 May;51(5):508-15. doi: 10.1248/cpb.51.508. Chem Pharm Bull (Tokyo). 2003. PMID: 12736449
-
Enantioselective dehydroxylation of enterodiol and enterolactone precursors by human intestinal bacteria.Biol Pharm Bull. 2007 Nov;30(11):2113-9. doi: 10.1248/bpb.30.2113. Biol Pharm Bull. 2007. PMID: 17978485
-
Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.Br J Nutr. 2010 Apr;103(7):929-38. doi: 10.1017/S0007114509992753. Epub 2009 Dec 15. Br J Nutr. 2010. PMID: 20003621 Review.
-
Assessing exposure to lignans and their metabolites in humans.J AOAC Int. 2006 Jul-Aug;89(4):1174-81. J AOAC Int. 2006. PMID: 16915861 Review.
Cited by
-
The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.Antioxidants (Basel). 2021 Jan 28;10(2):188. doi: 10.3390/antiox10020188. Antioxidants (Basel). 2021. PMID: 33525629 Free PMC article. Review.
-
Modulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat Diets.Int J Mol Sci. 2016 Jun 29;17(7):1002. doi: 10.3390/ijms17071002. Int J Mol Sci. 2016. PMID: 27367676 Free PMC article. Review.
-
Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans.Mol Nutr Food Res. 2019 Aug;63(16):e1801159. doi: 10.1002/mnfr.201801159. Epub 2019 Mar 26. Mol Nutr Food Res. 2019. PMID: 30817848 Free PMC article. Review.
-
Identification of the Microbial Transformation Products of Secoisolariciresinol Using an Untargeted Metabolomics Approach and Evaluation of the Osteogenic Activities of the Metabolites.Molecules. 2023 Jul 29;28(15):5742. doi: 10.3390/molecules28155742. Molecules. 2023. PMID: 37570714 Free PMC article.
-
Lignans and Gut Microbiota: An Interplay Revealing Potential Health Implications.Molecules. 2020 Dec 3;25(23):5709. doi: 10.3390/molecules25235709. Molecules. 2020. PMID: 33287261 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources